ArticleJournal of intensive medicine2022
Duration of acute kidney injury predicts 90-day mortality and chronic kidney disease progression in elderly patients.
Article in Journal of intensive medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 5 citations in OpenAlex.
- The prevalence and risk factors of acute kidney injury in post-orthopedic surgery patients.Frontiers in medicine · 2026Article
- Article
- Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.Intensive care medicine · 2024Article
- The duration of acute kidney injury is an additional parameter to predict 1-year survival in very elderly patients.Journal of intensive medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study evaluated the prognostic impact of acute kidney injury (AKI) duration on 90-d mortality and new-onset chronic kidney disease (CKD) progression in elderly patients. Methods: We retrospectively enrolled elderly patients (≥75 years; Results: Among patients, 62 (9.0%) had T-AKI (1-2 days), 104 (15.0%) had short-duration, 140 (20.2%) had medium-duration, and 387 (55.8%) had long-duration. In total, 209 (30.2%) died within 90 days; 122 (25.2%) developed CKD. After adjusting for multiple covariates, duration of AKI (3-4 days: hazard ratio [HR] = 2.512; Conclusion: AKI duration is useful for predicting poorer clinical outcomes in elderly patients, emphasizing the importance of identifying an appropriate treatment window for early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.